Health ❯ Medicine ❯ Patient Care

Cancer Treatment

Targeted Therapy Combination Therapies

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

Regulators limited the relaunch to one regimen because safety concerns offset strong efficacy data.